Recent
price
P/E
ratio
div
yld
- -
ROIC.AI
AtriCure to Participate in the 2024 Leerink Partners Healthcare Crossroads Conference
AtriCure, Inc. (NASDAQ:ATRC) Just Reported, And Analysts Assigned A US$47.33 Price Target
The past three years for AtriCure (NASDAQ:ATRC) investors has not been profitable
AtriCure First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
Unveiling AtriCure (ATRC)'s Value: Is It Really Priced Right? A Comprehensive Guide
AtriCure, Inc. (NASDAQ:ATRC) Q1 2024 Earnings Call Transcript
Analysts Offer Insights on Healthcare Companies: Idexx Laboratories (IDXX), Atricure (ATRC) and Bio-Techne (TECH)
Atricure’s Growth and Resilience Reinforce Buy Rating
AtriCure Inc (ATRC) Q1 2024 Earnings Call Transcript Highlights: Strong Revenue Growth and ...
AtriCure Inc (ATRC) Q1 2024 Earnings Call Transcript Highlights: Strong Revenue Growth and Strategic Innovations Set Positive Tone
Q1 2024 AtriCure Inc Earnings Call Transcript
AtriCure’s Strong Growth and Market Position Justify Buy Rating
Compared to Estimates, AtriCure (ATRC) Q1 Earnings: A Look at Key Metrics
Compared to Estimates, AtriCure (ATRC) Q1 Earnings: A Look at Key Metrics
AtriCure Inc (ATRC) Surpasses Revenue Estimates in Q1 2024 Despite Wider Losses
AtriCure (ATRC) Reports Q1 Loss, Tops Revenue Estimates
AtriCure (ATRC) Reports Q1 Loss, Tops Revenue Estimates
AtriCure Inc (ATRC) Surpasses Revenue Estimates in Q1 2024 Despite Wider Losses
AtriCure Reports First Quarter 2024 Financial Results
AtriCure Q1 2024 Earnings Preview
•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.